| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.08 |